Cargando…

Exploration of KIR genes and hematological-related diseases in Chinese Han population

The function of natural killer (NK) cells has previously been implicated in hematopoietic-related diseases. Killer immunoglobulin-like receptors (KIR) play an important role in NK cells after hematopoietic stem cell transplantation. To explore the immunogenetic predisposition of hematological-relate...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ye-Mo, Li, Yu-Xia, Hu, Xiao-Zhuang, Li, Dai-Yang, An, Lin, Yuan, Zhi-Yang, Liu, Zhong-Liang, Du, Ke-Ming, Zheng, Zhong-Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276034/
https://www.ncbi.nlm.nih.gov/pubmed/37328612
http://dx.doi.org/10.1038/s41598-023-36882-y
_version_ 1785059990928621568
author Li, Ye-Mo
Li, Yu-Xia
Hu, Xiao-Zhuang
Li, Dai-Yang
An, Lin
Yuan, Zhi-Yang
Liu, Zhong-Liang
Du, Ke-Ming
Zheng, Zhong-Zheng
author_facet Li, Ye-Mo
Li, Yu-Xia
Hu, Xiao-Zhuang
Li, Dai-Yang
An, Lin
Yuan, Zhi-Yang
Liu, Zhong-Liang
Du, Ke-Ming
Zheng, Zhong-Zheng
author_sort Li, Ye-Mo
collection PubMed
description The function of natural killer (NK) cells has previously been implicated in hematopoietic-related diseases. Killer immunoglobulin-like receptors (KIR) play an important role in NK cells after hematopoietic stem cell transplantation. To explore the immunogenetic predisposition of hematological-related diseases, herein, a multi-center retrospective study in China was conducted, analyzing and comparing 2519 patients with hematopathy (mainly, acute lymphoblastic leukemia, acute myeloid leukemia, aplastic anemia, and myelodysplastic syndrome) to 18,108 individuals without known pathology. Genotyping was performed by polymerase chain reaction with specific sequence primers (PCR-SSP). As a result, we discovered four genes including KIR2DL5 (OR: 0.74, 95% CI 0.59–0.93; Pc = 0.0405), 2DS1 (OR: 0.74, 95% CI 0.59–0.93; Pc = 0.0405), 2DS3 (OR: 0.58, 95% CI 0.41–0.81; Pc = 0.0180), and 3DS1 (OR: 0.74, 95% CI 0.58–0.94; Pc = 0.0405) to be protective factors that significantly reduce the risk of aplastic anemia. Our findings offer new approaches to immunotherapy for hematological-related diseases. As these therapies mature, they are promising to be used alone or in combination with current treatments to help to make blood disorders a manageable disease.
format Online
Article
Text
id pubmed-10276034
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-102760342023-06-18 Exploration of KIR genes and hematological-related diseases in Chinese Han population Li, Ye-Mo Li, Yu-Xia Hu, Xiao-Zhuang Li, Dai-Yang An, Lin Yuan, Zhi-Yang Liu, Zhong-Liang Du, Ke-Ming Zheng, Zhong-Zheng Sci Rep Article The function of natural killer (NK) cells has previously been implicated in hematopoietic-related diseases. Killer immunoglobulin-like receptors (KIR) play an important role in NK cells after hematopoietic stem cell transplantation. To explore the immunogenetic predisposition of hematological-related diseases, herein, a multi-center retrospective study in China was conducted, analyzing and comparing 2519 patients with hematopathy (mainly, acute lymphoblastic leukemia, acute myeloid leukemia, aplastic anemia, and myelodysplastic syndrome) to 18,108 individuals without known pathology. Genotyping was performed by polymerase chain reaction with specific sequence primers (PCR-SSP). As a result, we discovered four genes including KIR2DL5 (OR: 0.74, 95% CI 0.59–0.93; Pc = 0.0405), 2DS1 (OR: 0.74, 95% CI 0.59–0.93; Pc = 0.0405), 2DS3 (OR: 0.58, 95% CI 0.41–0.81; Pc = 0.0180), and 3DS1 (OR: 0.74, 95% CI 0.58–0.94; Pc = 0.0405) to be protective factors that significantly reduce the risk of aplastic anemia. Our findings offer new approaches to immunotherapy for hematological-related diseases. As these therapies mature, they are promising to be used alone or in combination with current treatments to help to make blood disorders a manageable disease. Nature Publishing Group UK 2023-06-16 /pmc/articles/PMC10276034/ /pubmed/37328612 http://dx.doi.org/10.1038/s41598-023-36882-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Li, Ye-Mo
Li, Yu-Xia
Hu, Xiao-Zhuang
Li, Dai-Yang
An, Lin
Yuan, Zhi-Yang
Liu, Zhong-Liang
Du, Ke-Ming
Zheng, Zhong-Zheng
Exploration of KIR genes and hematological-related diseases in Chinese Han population
title Exploration of KIR genes and hematological-related diseases in Chinese Han population
title_full Exploration of KIR genes and hematological-related diseases in Chinese Han population
title_fullStr Exploration of KIR genes and hematological-related diseases in Chinese Han population
title_full_unstemmed Exploration of KIR genes and hematological-related diseases in Chinese Han population
title_short Exploration of KIR genes and hematological-related diseases in Chinese Han population
title_sort exploration of kir genes and hematological-related diseases in chinese han population
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276034/
https://www.ncbi.nlm.nih.gov/pubmed/37328612
http://dx.doi.org/10.1038/s41598-023-36882-y
work_keys_str_mv AT liyemo explorationofkirgenesandhematologicalrelateddiseasesinchinesehanpopulation
AT liyuxia explorationofkirgenesandhematologicalrelateddiseasesinchinesehanpopulation
AT huxiaozhuang explorationofkirgenesandhematologicalrelateddiseasesinchinesehanpopulation
AT lidaiyang explorationofkirgenesandhematologicalrelateddiseasesinchinesehanpopulation
AT anlin explorationofkirgenesandhematologicalrelateddiseasesinchinesehanpopulation
AT yuanzhiyang explorationofkirgenesandhematologicalrelateddiseasesinchinesehanpopulation
AT liuzhongliang explorationofkirgenesandhematologicalrelateddiseasesinchinesehanpopulation
AT dukeming explorationofkirgenesandhematologicalrelateddiseasesinchinesehanpopulation
AT zhengzhongzheng explorationofkirgenesandhematologicalrelateddiseasesinchinesehanpopulation